MARTINGALE ASSET MANAGEMENT L P - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 200 filers reported holding ANI PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,338,618
+5.1%
21,021
+14.1%
0.03%
+16.0%
Q1 2024$1,274,136
+35.8%
18,431
+8.3%
0.02%
+31.6%
Q4 2023$938,483
-5.0%
17,0200.0%0.02%
-9.5%
Q3 2023$988,182
+7.9%
17,020
-0.0%
0.02%
+16.7%
Q2 2023$916,241
+42.2%
17,021
+4.9%
0.02%
+50.0%
Q1 2023$644,299
-1.3%
16,2210.0%0.01%
-7.7%
Q4 2022$652,571
+27.2%
16,221
+1.9%
0.01%
+30.0%
Q3 2022$513,000
+34.6%
15,926
+24.2%
0.01%
+42.9%
Q2 2022$381,000
+31.4%
12,826
+24.4%
0.01%
+75.0%
Q1 2022$290,000
-33.9%
10,309
+8.4%
0.00%
-33.3%
Q4 2021$439,000
-34.8%
9,508
-60.1%
0.01%
-25.0%
Q3 2020$673,000
-58.8%
23,809
-52.9%
0.01%
-57.9%
Q2 2020$1,635,000
-20.6%
50,509
-0.0%
0.02%
-29.6%
Q1 2020$2,059,000
-17.0%
50,513
+25.6%
0.03%
+8.0%
Q4 2019$2,481,000
-25.4%
40,212
-11.8%
0.02%
-26.5%
Q3 2019$3,325,000
-5.1%
45,612
+7.0%
0.03%
-8.1%
Q2 2019$3,503,000
+83.1%
42,611
+57.2%
0.04%
+76.2%
Q1 2019$1,913,000
+82.2%
27,109
+16.3%
0.02%
+50.0%
Q4 2018$1,050,00023,3090.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 239,101$8,380,0002.93%
Mesirow Financial Investment Management, Inc. 8,974$315,0000.80%
Parkman Healthcare Partners LLC 55,346$1,940,0000.42%
1492 Capital Management LLC 18,178$637,0000.32%
INVESTMENT COUNSELORS OF MARYLAND LLC 383,696$13,449,0000.31%
PERKINS CAPITAL MANAGEMENT INC 14,076$493,0000.28%
HUSSMAN STRATEGIC ADVISORS, INC. 30,400$1,066,0000.22%
Defender Capital, LLC. 19,000$665,0000.22%
Ranger Investment Management 104,941$3,678,0000.19%
THOMPSON SIEGEL & WALMSLEY LLC 380,474$13,336,0000.18%
View complete list of ANI PHARMACEUTICALS INC shareholders